Hydroxychloroquine in Primary Progressive Multiple Sclerosis

Clinical trial NCT02913157 · COMPLETED

Trial details

NCT number: NCT02913157
Sponsor: University of Calgary
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis, Primary Progressive

Start date: 2016-11-01
Primary completion: 2021-06-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.